Vistagen Therapeutics Q1 2026 Earnings Narrower Loss Than Expected Boosts Investor Sentiment CVI Q1 2026 Earnings EPS Misses by Over 210 Amid Refining Headwinds NAT Q4 2025 Earnings Significant EPS Miss Sends Stock Lower DDS Q1 2026 Earnings EPS Falls Short of Estimates Amid Challenging Retail Environment OCC Q1 2026 Earnings Net Loss of 005 Per Share Reported Stock Gains 788 OTIS Q1 2026 Earnings EPS Falls Short of Estimates Amid Mixed Demand